Cite Filings / SCTX
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)

CIK 0001853921

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Scribe Therapeutics, Inc.

Sign in to watch
Ticker
SCTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
822157847
Phone
+1 510-454-0213
Business address
1150 MARINA VILLAGE PKWY, ALAMEDA, CA, 94501
Filings Financials Insiders Search text
All 49 Financials 5 Executive Compensation 3 Insider Trading 25 Beneficial Ownership Interest 5 Business Combinations 3 Public Offerings 4 Others 10
›
Filed in
  1. No filings match these filters. Clear filters
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-11-16
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-03
  4. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-07-30
  5. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-07-30
  6. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-07-29

Page 1 of 1 · 5 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…